Market
-
Claros Mortgage Trust pauses common stock dividend
Claros Mortgage Trust pauses common stock dividend Source link
Read More » -
Saudi oil price cut for Asia buyers underscores weakening market outlook (NYSEARCA:USO)
Dec. 09, 2024 6:50 PM ETUnited States Oil Fund, LP ETF (USO), CL1:COMUCO, DBO, UNG, FCG, USL, SCO, UNL, BNO, BOIL, KOLD, GUSH, DRIP, USOI, CO1:COM, NG1:COMBy: Carl Surran, SA News Editor SlavkoSereda/iStock via Getty Images Crude oil futures finished higher Monday after China eased its overall monetary policy stance for the first time in 14 years, and as the…
Read More » -
Zscaler CFO Canessa retires after holding position for nearly eight years
hapabapa/iStock Editorial via Getty Images Zscaler (NASDAQ:ZS) Chief Financial Officer Remo Canessa is retiring after serving in the position for nearly eight years. “His decision to retire is not the result, in whole or in part, of any disagreement with the Company on any matters relating to Source link
Read More » -
Here’s the major earnings before the open tomorrow
Nov. 25, 2024 6:00 PM ETM, BBY, ANF, ADI, KSS, DKS, TEN, SJM, TITN, HTHT, MANU, BURL, MDWD, VFSBy: Pranav Ghumatkar, SA News Editor Major earnings expected before the bell on Tuesday include: Analog Devices (ADI) Abercrombie & Fitch (ANF) Best Buy (BBY) Kohl’s (KSS) Macy’s (M) Other earnings slated for release before Tuesday’s open include: BURL, DKS, HTHT, MANU,…
Read More » -
Gold soars on Russia-Ukraine fears, lower dollar; Goldman reiterates $3,000 gold forecast
Nov. 18, 2024 6:30 PM ETSPDR® Gold Shares ETF (GLD), GDXIAU, SLV, SIL, SGOL, SIVR, GDXJ, PHYS, PSLV, NUGT, RING, OUNZ, SILJ, BAR, GLDM, AAAU, XAGUSD:CUR, XAUUSD:CURBy: Carl Surran, SA News Editor monsitj/iStock via Getty Images Gold futures surged Monday to top $2,600/oz, snapping a six-session losing streak, as renewed uncertainty over the Russia-Ukraine conflict sparked a resurgence of safe-haven…
Read More » -
Warning: NTBLQ is at high risk of performing badly
Warning: NTBLQ is at high risk of performing badly Source link
Read More » -
Journey gets FDA okay for Emrosi, releases preliminary Q3 earnings report (NASDAQ:DERM)
Andrzej Rostek Journey Medical (NASDAQ:DERM) has received FDA approval for its drug Emrosi for the treatment of rosacea. Emrosi is the brand name for minocycline hydrochloride extended release 40 mg capsules. The product was developed with Dr. Reddy’s Laboratories (NYSE:RDY). Journey anticipates Source link
Read More » -
Warning: NTBLQ is at high risk of performing badly
Warning: NTBLQ is at high risk of performing badly Source link
Read More » -
Warning: TSBX is at high risk of performing badly
Warning: TSBX is at high risk of performing badly Source link
Read More » -
Here’s the major earnings before the open tomorrow
Oct. 14, 2024 6:00 PM ETSCHW, BAC, GS, ERIC, C, JNJ, UNH, STT, PNC, WBA, ACIBy: Pranav Ghumatkar, SA News Editor Major earnings expected before the bell on Tuesday include: Bank of America (BAC) Citigroup (C) The Goldman Sachs Group (GS) Johnson & Johnson (JNJ) UnitedHealth Group (UNH) Other earnings slated for release before Tuesday’s open include: Source link
Read More »